Association between asthma control and Interleukin-17F expression levels in adult patients with atopic asthma

References

1. ↵
   1. Global Initiative for Asthma

   Global strategy for asthma management and prevention [Updated 2015], Available from URL: http://ginasthma.org/wp-content/uploads/2016/01/GINA_Pocket_2015.pdf.
2. ↵
   1. Sudoyo AW,
   2. Setiyohadi B,
   3. Alwi I,
   4. Simadibrata M,
   5. Setiati S

   1. Sundaru H

   (2014) in Buku Ajar Ilmu Penyakit Dalam edisi ke 6, Sukamto. Asma bronkial, eds Sudoyo AW, Setiyohadi B, Alwi I, Simadibrata M, Setiati S (Internal Publishing, Jakarta).
3. ↵
   1. Lazarus S

   (2010) Emergency Treatment of Asthma. N Eng J Med 363:755–764.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   1. Centers for Disease Control and Prevention

   Data from the CDC National Asthma Control Program 2012 [Internet] (Atlanta, GA) Available from: http://www.cdc.gov/asthma/pdfs/investment_americas_health.pdf. [cited 2015 Oct 6].
5. ↵
   1. Ten Hacken NH,
   2. Oosterhoff Y,
   3. Kauffman HF,
   4. Guevarra L,
   5. Satoh T,
   6. Tollerud DJ,
   7. et al.

   (1998) Elevated serum interferon- in atopic asthma correlates with increased airways responsiveness and circadian peak expiratory flow variation. Eur Respir J 11:312–316.

   OpenUrlAbstract
6. ↵
   1. Holgate ST

   (2012) Innate and adaptive immune responses in asthma. Nature Medicine 18:673–685.

   OpenUrlCrossRefPubMed
7. ↵
   1. Ota K,
   2. Kawaguchi M,
   3. Matsukura S,
   4. Kurokawa M,
   5. Kokubu F

   (2014) Potensial Involvement of IL-17F in Asthma. J Immunol Res 2014:602846.

   OpenUrl
8. ↵
   1. Nathan RA,
   2. Sorkness CA,
   3. Kosinski M,
   4. Schatz M,
   5. Li JT,
   6. et al.

   (2004) Development of the Asthma Control. A survey for assessing asthma control. J Allergy Clin Immunol 113:59–65.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Sterk PJ,
   2. Lutter R

   (2014) Asthma phenotyping: TH2-high, TH2 low and beyond. J Allergy Clin Immunol 133:395–396.

   OpenUrl
10. ↵
    1. Woodruff PG,
    2. Modrek B,
    3. Choy DF,
    4. Jia G,
    5. Abbas AR,
    6. Ellwanger A,
    7. et al.

    (2009) T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 180:388–395.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Hansen G,
    2. Berry G,
    3. DeKruyff RH,
    4. Umetsu DT

    (1999) Allergen-spesific Th1 cells fail to counterbalance Th2 cell-induced airway hyperactivity but cause severe airway inflammation. J Clin Invest 103:175–183.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    1. Kim YM,
    2. Kim YS,
    3. Jeon SG,
    4. Kim YK

    (2013) Immunopathogenesis of allergic asthma: more than the Th2 hypothesis. Allergy Asthma Immunol Res 5:189–196.

    OpenUrlCrossRefPubMed
13. ↵
    1. Pappu R,
    2. Carrozzi VR,
    3. Sambandam A

    (2011) The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Immunology 134:8–16.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    1. Jin W,
    2. Dong C

    (2013) IL-17 cytokines in immunity and inflammation. Emerging Microbes and Infections 2:1–5.

    OpenUrlCrossRef
15. ↵
    1. Bazzi MD,
    2. Sultan MA,
    3. Tassan AI,
    4. Alanazi M,
    5. Al-Amri A,
    6. et al.

    (2013) Interleukin (IL)-17A and IL-17F and Asthma in Saudi Arabia: mRNA transcript level and gene Polymorphisms. African Journal of Biotechnology 12:3615–36210.

    OpenUrl
16. ↵
    1. Chang SH,
    2. Dong C

    (2009) IL-17F: regulation, signaling and function in inflammation. Cytokine 46:7–11.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    1. Yang XO,
    2. Chang SH,
    3. Park H,
    4. Nurieva R,
    5. Shah B,
    6. Acero L,
    7. et al.

    (2008) Regulation of inflammatory responses by IL-17F. J Exp Med 205:1063–1075.

    OpenUrlAbstract/FREE Full Text
18. ↵
    1. Sorbello V,
    2. Ciprandi G,
    3. Stefano AD,
    4. Massaglia GM,
    5. Favata G,
    6. Conticello S,
    7. et al.

    (2015) Nasal IL-17F is related to bronchial IL-17F/neutrophilia and exacerbations in stable atopic severe asthma. Allergy 70:236–240.

    OpenUrl
19. 1. Alyasin S,
    2. Karimi MH,
    3. Amin R,
    4. Babaei M,
    5. Darougar S

    (2013) Interleukin-17 gene expression and serum levels in children with severe asthma. Iran J Immunol 10:179–187.

    OpenUrl
20. 1. Agache I,
    2. Ciobanu C,
    3. Agache C,
    4. Anghel M

    (2010) Increased serum IL-17 is an independent risk factor for severe asthma. Respiratory Medicine 104:1131–1137.

    OpenUrlCrossRefPubMed
21. ↵
    1. Al-Ramli W,
    2. Prefontaine D,
    3. Chouiali F,
    4. Martin JG,
    5. Olivenstein R,
    6. Lemiere C,
    7. et al.

    (2009) TH17-associated cytokine (IL17-A and IL-17F) in severe asthma. J Allergy Clin Immunol 123:1185–1187.

    OpenUrlCrossRefPubMedWeb of Science
22. ↵
    1. Choy DF,
    2. Hart KM,
    3. Borthwick LA,
    4. Shikotra A,
    5. Nagarkar DR,
    6. Siddiqui S,
    7. et al.

    (2015) TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma. Sci Transl Med 7:301ra129.

    OpenUrlAbstract/FREE Full Text
23. ↵
    1. Oda N,
    2. Canelos PB,
    3. Essayan DM,
    4. Plunkett BA,
    5. Myers AC,
    6. Huang SK

    (2005) Interleukin-17F induces pulmonary neutrophilia and amplifies antigen-induced allergic response. Am J Respir Crit Care Med 171:12–18.

    OpenUrlCrossRefPubMedWeb of Science